Pharma Markets

US Obesity Market Analysis and Competitive Landscape Highlights

By Fore Pharma | Published Date: May 24, 2020 | On-Demand Data

US Obesity Market Analysis and Competitive Landscape Highlights – 2020, provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market valuations and forecast, Obesity drugs sales and competitive landscape in the US.

Research Scope:

– Obesity Pipeline: Drugs in clinical trials for the treatment of Obesity by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
– Obesity Epidemiology: Number of patients diagnosed (prevalence) with Obesity in the US
– Drugs sales: Sales revenues for Obesity drugs in the US
– Market valuations: US Obesity market size for in 2019; find out how the market advanced from 2016 and forecast to 2025
– Drugs market share: Market shares for key Obesity drugs in the US

This research helps executives to

– Support monitoring and reporting national Obesity market analysis and sales trends
– Track competitor drugs sales and market share in the US Obesity market
– Track competitive developments in Obesity market and present key issues and learnings
– Synthesize insights for Obesity market and products to drive business performance
– Answer key business questions about the Obesity market
– Evaluate commercial market opportunity assessment, positioning, and segmentation for Obesity products
– Supports decision making in R&D to long term marketing strategies

Table of Contents


1) Obesity Treatments
2) Obesity Drugs Pipeline
3) US Obesity Epidemiology
4) Marketed Drugs for Obesity in the US
5) Obesity Market Size and Forecast
6) Obesity Drugs Sales and Forecast
7) Obesity Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables


1. Obesity Phase 3 Clinical Trials, 2020
2. Obesity Phase 2 Clinical Trials, 2020
3. Obesity Phase 1 Clinical Trials, 2020
4. Obesity Epidemiology, US, 2016 – 2025
5. Marketed Drugs for Obesity, US, 2019
6. Obesity Market Size and Forecast ($mn), US, 2016 – 2025
7. Obesity Drugs Sales ($mn), US, 2016 – 2025

List of Figures


1. Obesity Epidemiology, US, 2016 – 2025
2. Obesity Market Size and Forecast ($mn), US, 2016 – 2025
3. Obesity Drugs Market Share (%), US, 2019

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies